Form 4: GE HealthCare Director Rodney Hochman Boosts Equity Stake Through Stock Awards
Insider Transaction Report
GE HealthCare Technologies Inc. Director Rodney F. Hochman acquired 4,848 shares of common stock through restricted and deferred stock unit awards on May 28, 2025, increasing his total beneficial ownership to 13,611 shares.
Summary
- Rodney F. Hochman, a Director of GE HealthCare Technologies Inc. (GEHC), reported changes in his beneficial ownership of the company's common stock.
- On May 28, 2025, Mr. Hochman acquired 3,092 shares of common stock in the form of restricted stock units (RSUs).
- These RSUs will vest 100% on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
- On the same date, Mr. Hochman also acquired 1,756 shares of common stock as fully vested deferred stock units (DSUs).
- The DSUs were elected by Mr. Hochman in lieu of 100% of his cash retainer, in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan.
- Both awards were granted at a price of $0 per share, indicating they are compensation-based awards.
- Following these transactions, Mr. Hochman's total beneficial ownership of GE HealthCare common stock increased to 13,611 shares.
Sentiment
Score: 6
Explanation: The sentiment is slightly positive as it indicates a director increasing their equity stake, aligning their interests with shareholders. However, it's a routine compensation event, not indicative of extraordinary news.
Positives
- The acquisition of additional equity by a director, Rodney F. Hochman, through stock awards aligns his interests more closely with those of the company's shareholders.
- The use of deferred stock units in lieu of cash retainer demonstrates a director's confidence in the company's long-term value and a preference for equity-based compensation.
Future Outlook
The document indicates that the 3,092 restricted stock units will vest on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026. Settlement of both restricted and deferred stock units will occur pursuant to the reporting person's applicable deferral election in accordance with the company's compensation plan.
Industry Context
This Form 4 filing reflects a routine compensation event for a director, common across publicly traded companies in various industries, including healthcare technology, to align management and board interests with shareholder value through equity awards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Reference | The awards were made in accordance with GE HealthCare's Non-Employee Director Compensation and Benefits Plan (the 'Plan'), indicating a structured approach to director remuneration. | 05/28/2025 | Reinforces the company's established governance framework for director compensation, promoting transparency and alignment of interests. |
Stakeholder Impact
- Shareholders: The increase in director equity ownership through compensation awards generally aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders.
Next Steps
- Vesting of the 3,092 restricted stock units on the earlier of GE HealthCare's next annual meeting of stockholders or May 28, 2026.
- Settlement of vested restricted stock units and deferred stock units based on the reporting person's deferral election.
Key Dates
| Date | Description |
|---|---|
| 05/28/2025 | Date of earliest transaction, when Rodney F. Hochman acquired restricted and deferred stock units. |
| 05/30/2025 | Date the Form 4 was signed by Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact. |
| 05/28/2026 | Latest possible vesting date for the 3,092 restricted stock units. |
Keywords
GE HealthCare, GEHC, Form 4, Insider Transaction, Stock Award, Restricted Stock Units, Deferred Stock Units, Director Compensation, Equity Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.